Tag Archives: Biotechnology

Viatris Studies Robust Third Quarter 2022 Outcomes

Reaffirms 2022 Steering Ranges [1] Throughout Whole Revenues, Adjusted EBITDA and Free Money Stream; Pushed by Strong Working Momentum Regardless of International Change Headwinds and Absorbing Inflation Impression to Date Studies Whole Revenues of $4.08 billion; U.S. GAAP Internet Earnings of $354 million; Adjusted EBITDA of $1.50 billion; U.S. GAAP Internet Money Offered by Working Actions of $869… Read More »